Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-04-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
天健会计师事务所（特殊普通合伙）关于益丰大药房连锁股份有限公司2022年度募集资金存放与使用情况鉴证报告
Regulatory Filings
2023-04-27 Chinese
《公司章程》（2023年4月修订）
Governance Information Classification · 100% confidence The document is titled "益丰大药房连锁股份有限公司 公司章程" which translates to "Yifeng Pharmacy Chain Co., Ltd. Articles of Association" or "Company Charter." The content includes detailed provisions on company organization, shareholder rights, board structure, management, financial accounting, profit distribution, and other governance matters. It references laws such as the Company Law and Securities Law of China and covers topics like shareholder meetings, board of directors, supervisory board, and amendments to the articles. There is no indication that this is a financial report, earnings release, or announcement. Instead, it is a governance document detailing the internal rules and structure of the company. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial and contains the full text of the articles, not just an announcement or summary, so it is not an RPA or RNS.
2023-04-27 Chinese
益丰药房关于2023年第一季度主要经营数据的公告
Interim / Quarterly Report Classification · 95% confidence The document is titled as an announcement regarding the company's main operating data for the first quarter of 2023. It contains detailed financial and operational data such as revenue, net profit, cash flow, segment revenue, store expansion, and insurance qualification status. The document is relatively short (2949 characters) and focuses on quarterly performance data rather than a full comprehensive report. It does not appear to be a full interim or quarterly report with complete financial statements, but rather a summary announcement of key operating metrics for the quarter. This fits the category of an Interim / Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2023
2023-04-27 Chinese
独立董事关于公司第四届董事会第二十四次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions on matters to be discussed at the company's 24th board meeting of the 4th session. It mentions the proposal to reappoint the accounting firm for the 2023 audit and the expected related party transactions for 2023. The document is short (660 characters) and does not contain financial statements or detailed financial data. It is a governance-related document concerning board meeting matters and approvals, not a full audit report or annual report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters.
2023-04-27 Chinese
益丰药房关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from the company Yifeng Pharmacy Chain Co., Ltd. regarding the appointment of a senior management personnel, specifically the appointment of Ms. Wan Xuemei as Vice President. It includes details about the board meeting approving the appointment, the independent directors' opinions, and a brief resume of the appointee. There is no financial data, earnings information, or regulatory filings related to financial performance. The content clearly relates to management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on the appointment, confirming it is not a full report or other type of filing.
2023-04-27 Chinese
益丰药房关于为子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by Yifeng Pharmacy Chain Co., Ltd. regarding the provision of guarantees for bank credit applications by its subsidiaries. It details the guarantee amounts, the subsidiaries involved, their financial status, and the board's approval and opinions. The content focuses on the company's financing activities related to guarantees for subsidiaries' bank credit, including risk disclosures and compliance with legal procedures. There are no financial statements or comprehensive financial performance data typical of annual or interim reports. The document is not a report itself but an announcement about a capital/financing update related to guarantees. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (5031 characters) and detailed financial data about guarantees support this classification with high confidence.
2023-04-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.